Abstract

Introduction

Renal dose adjustments for gabapentin and pregabalin are ubiquitously evident in the medical literature. All manufacturers for these branded and generic dosage forms list dosing recommendations relative to creatinine clearance (CrCl) for both medications (Table 1).1,2 However, the basis of these recommendations has not been well articulated.

Details

Title
Rational dosing of gabapentin and pregabalin in chronic kidney disease
Author
Mena Raouf; Atkinson, Timothy J; Crumb, Meredith W; Fudin, Jeffrey
Pages
275-278
Section
Editorial
Publication year
2017
Publication date
2017
Publisher
Taylor & Francis Ltd.
e-ISSN
1178-7090
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2296754429
Copyright
© 2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.